-
HIV Can Worsen Cancer Treatment OutcomesPeople with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment.
by Jon Kelvey
-
Why Is the Rate of Uterine Cancer Rising?Uterine cancer incidence is increasing in the U.S., particularly in Hispanic, Asian and black women, but obesity may play a smaller role in this change than was previously assumed.
by Ashley P. Taylor
-
Cancer Care on a Native American ReservationFor the first time, people living in the Navajo Nation who are diagnosed with cancer can get treated for the disease without leaving tribal lands.
by Kate Yandell
-
Risk Reduction, Clinical Trials Are Focus of Atlanta Community EventCancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research.
by Kevin McLaughlin
-
2018: This Year in Cancer NewsThe Cancer Today editorial staff selects some of the most interesting and impactful reporting, research and perspectives of 2018.
by Cancer Today Staff
-
Reinforcements for Cancer ResearchScientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities.
by Marci A. Landsmann
-
Does Medicaid Expansion Have an Impact?Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients.
by Marci A. Landsmann
-
Achieving Health EqualityNational Cancer Institute director Norman “Ned” Sharpless describes the challenge and opportunity of studying cancer disparities.
by Marci A. Landsmann
-
The Roots of Rural Health DisparitiesNew research shows that rural cancer patients have the same health outcomes as urban cancer patients so long as they are involved in a clinical trial.
by Cheryl Platzman Weinstock
-
A New Guideline for Cervical Cancer ScreeningPhysicians Lee Learman and Francisco Garcia discuss the updated U.S. Preventive Services Task Force guideline and the need to increase access to cervical cancer screening.
by Anna Azvolinsky
Challenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
